Tranzactioneaza Tenax Therapeutics (US.TENX) - 11.48 USD (%) Tranzactioneaza
Indici
Descriere companie
Tenax Therapeutics, Inc. (http://www.tenaxthera.com/) is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases of unmet medical need. The Company's products include TNX-103 (oral levosimendan) and TNX-201 (oral enteric coated imatinib). The Company's lead product, Levosimendan, is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. It has completed Phase II clinical trial of levosimendan in North America for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). It is also developing an oral formulation of imatinib mesylate, a kinase inhibitor, for the treatment of pulmonary arterial hypertension (PAH).